• locale

  Australia

• market

  STOCKS

• industry

  Biotechnology

• website

  regeneus.com.au

• ipo date

  Sep 19, 2013

Regeneus Ltd, a clinical stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain, and dermatology diseases in Australia. Its lead platform technology includes Progenza, a multi-synergistic therapy for the treatment of osteoarthritis and neuropathic pain. ...Show More

*Estimate based on analyst consensus